Your browser doesn't support javascript.
loading
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Hill, Brian T; Ahn, Kwang Woo; Hu, Zhen-Huan; Aljurf, Mahmoud; Beitinjaneh, Amer; Cahn, Jean-Yves; Cerny, Jan; Kharfan-Dabaja, Mohamed A; Ganguly, Siddhartha; Ghosh, Nilanjan; Grunwald, Michael R; Inamoto, Yoshihiro; Kindwall-Keller, Tamila; Nishihori, Taiga; Olsson, Richard F; Saad, Ayman; Seftel, Matthew; Seo, Sachiko; Szer, Jeffrey; Tallman, Martin; Ustun, Celalettin; Wiernik, Peter H; Maziarz, Richard T; Kalaycio, Matt; Alyea, Edwin; Popat, Uday; Sobecks, Ronald; Saber, Wael.
Afiliação
  • Hill BT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address: hillb2@ccf.org.
  • Ahn KW; Center for International Blood and Marrow Transplantation and Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hu ZH; Center for International Blood and Marrow Transplantation and Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia.
  • Beitinjaneh A; University of Miami, Miami, Florida.
  • Cahn JY; Department of Hematology, University Hospital, Grenoble, France.
  • Cerny J; UMass Memorial Medical Center, Worcester, Massachusetts.
  • Kharfan-Dabaja MA; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Ganguly S; Blood and Marrow Transplantation, Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, Kansas.
  • Ghosh N; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Kindwall-Keller T; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Olsson RF; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Saad A; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Seftel M; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada.
  • Seo S; Department of Hematology and Oncology, National Cancer Research Center East, Chiba, Japan.
  • Szer J; Department of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Victoria, Australia.
  • Tallman M; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ustun C; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Wiernik PH; Our Lady of Mercy Medical Center, Bronx, New York.
  • Maziarz RT; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Kalaycio M; Cleveland Clinic, Cleveland, Ohio.
  • Alyea E; Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Popat U; M.D. Anderson Cancer Center, Houston, Texas.
  • Sobecks R; Cleveland Clinic, Cleveland, Ohio.
  • Saber W; Center for International Blood and Marrow Transplantation and Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Biol Blood Marrow Transplant ; 24(3): 581-586, 2018 03.
Article em En | MEDLINE | ID: mdl-29032274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste de Histocompatibilidade / Leucemia Linfocítica Crônica de Células B / Transplante de Células-Tronco Hematopoéticas / Antígenos HLA Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste de Histocompatibilidade / Leucemia Linfocítica Crônica de Células B / Transplante de Células-Tronco Hematopoéticas / Antígenos HLA Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2018 Tipo de documento: Article